Approved for patients 5 years or older with sickle cell disease.

Patients treated with L-glutamine versus placebo had fewer hospitalizations, sickle cell crises, fewer days spent in the hospital, than placebo.

Associated with fewer chest crises.

Most common adverse events: Constipation, nausea, abdominal pain, headache, cough, extremity back and chest pain.

Leave a Reply

Your email address will not be published. Required fields are marked *